Wide distribution of Naloxone effective in preventing opioid-related deaths
Broad distribution of the opioid reversal drug naloxone is highly cost-effective in reducing fatal overdoses, according to a new University […]
» Read moreHome »
Scientists were a step closer to a cure for Ebola on Monday after two of four drugs in a clinical […] Researchers at Yale University have identified how naltrexone, a medication used to treat alcohol use disorder, reduces craving and consumption […] (HealthDay)—Dupilumab is associated with significantly reduced severe exacerbation rates in patients with late-onset asthma with or without fixed airway obstruction, […] The prevalence of using antidepressants and proton pump inhibitors increases after the diagnosis of Alzheimer’s disease, according to a doctoral […] 1) Gather all your medications and put them in one place. If you have medications in different places throughout your […] Today, many disease-causing bacteria acquire resistance genes, which make antibiotic treatment ineffective. One gene especially—CTX-M-15, encoding an extended spectrum beta-lactamase […] NEW HAVEN, Conn., Feb. 4, 2019 /PRNewswire/ — Biohaven Pharmaceutical Holding Company Ltd. (NYSE: BHVN), a biotechnology company focused on […] KENILWORTH, N.J.–(BUSINESS WIRE) January 30, 2019 –Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today […] The sweltering backwaters of Indonesian Borneo have become the unlikely ground zero for the global production and export of Kratom, […]
Two Ebola drugs found to increase survival rates: health officials
Kappa opioid receptor influences naltrexone’s effects on drinking alcohol
Dupilumab cuts exacerbations in late-onset asthma
Symptomatic pharmacotherapy should be regularly assessed among older persons and those with Alzheimer’s disease
How To Organize Your Medicine Cabinet Like a Pro – GoodRx
Cocktail of common antibiotics can fight resistant E. coli
Biohaven Achieves Targeted Therapeutic Exposures of BHV-3500, a Third-Generation Small Molecule CGRP Receptor Agonist
Merck Receives Breakthrough Therapy Designation from FDA for V114, the Company’s Investigational 15-Valent Conjugate Vaccine for the Prevention of Invasive Pneumococcal Disease, in Infants, Children, and Adolescents
Miracle treatment or dangerous drug? Indonesia cashes in on Kratom
